Literature DB >> 16963078

Cardiomyocyte-restricted deletion of connexin43 during mouse development.

Dominik Eckardt1, Susanne Kirchhoff, Jung-Sun Kim, Joachim Degen, Martin Theis, Thomas Ott, Frank Wiesmann, Pieter A Doevendans, Wouter H Lamers, Jacques M T de Bakker, Harold V M van Rijen, Michael D Schneider, Klaus Willecke.   

Abstract

Although the gap junction protein Connexin43 (Cx43) is expressed in various cell types during embryonic development, mice with a global inactivation of Cx43 survive until birth but die perinatally due to an obstruction of the right ventricular outflow tract of the heart. To analyze the functional role of Cx43 gap junction channels in cardiomyocytes of the developing and early postnatal heart, we used alphaMyHC-Cre mice to ablate Cx43 expression selectively in cardiomyocytes during development. We found efficient ablation of Cx43 in cardiomyocytes during embryonic development starting at embryonic day (ED) 9.5 in the ventricular wall. Analyses of cardiac Cx43 protein at birth indicated complete loss of Cx43 expression in cardiomyocytes. All mice homozygously deficient for Cx43 in cardiomyocytes died until postnatal day (PD) 16. Heterozygous inactivation of Cx43 in cardiomyocytes neither altered atrial nor ventricular activation, but homozygous ablation led to changes in ventricular activation, i.e. significant decrease of the QRS-amplitude and prolonged QRS-duration already at PD 4. Cardiac morphology was similar to controls until PD 1, but subtle morphological changes were found in a subgroup of mutant mice at later stages. Besides narrowing of the ventricular outlet region at PD 6, hypertrophy of ventricular myocardium was found at PD 12. Our data indicate that complete inactivation of cardiac Cx43 during development predisposes hearts to develop postnatal morphological alterations, which differ from outflow tract obstructions described for Cx43 null mice. In addition, complete loss of cardiac Cx43 protein during development correlates with slowed ventricular activation at PD 4, impairs viability during development, and leads to death of all mutant mice until PD 16.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963078     DOI: 10.1016/j.yjmcc.2006.07.017

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  19 in total

1.  Tbx6 is a determinant of cardiac and neural cell fate decisions in multipotent P19CL6 cells.

Authors:  Svetlana Gavrilov; Thomas G Nührenberg; Anthony W Ashton; Chang-Fu Peng; Jennifer C Moore; Klitos Konstantinidis; Christine L Mummery; Richard N Kitsis
Journal:  Differentiation       Date:  2012-06-19       Impact factor: 3.880

2.  MicroRNA expression, target genes, and signaling pathways in infants with a ventricular septal defect.

Authors:  Hui Chai; Zhaoyuan Yan; Ke Huang; Yuanqing Jiang; Lin Zhang
Journal:  Mol Cell Biochem       Date:  2017-08-18       Impact factor: 3.396

Review 3.  Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease.

Authors:  Antonio Rodríguez-Sinovas; Jose Antonio Sánchez; Laura Valls-Lacalle; Marta Consegal; Ignacio Ferreira-González
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

4.  Connexin43 dephosphorylation at serine 282 is associated with connexin43-mediated cardiomyocyte apoptosis.

Authors:  Yutong Yang; Xinxin Yan; Jingyi Xue; Yuanyuan Zheng; Min Chen; Zhipeng Sun; Tiantian Liu; Cong Wang; Hongjie You; Dali Luo
Journal:  Cell Death Differ       Date:  2019-02-15       Impact factor: 15.828

5.  Effects of substitution of Cx43 by Cx32 on myocardial energy metabolism, tolerance to ischaemia and preconditioning protection.

Authors:  Antonio Rodríguez-Sinovas; Jose A Sánchez; Alejandra González-Loyola; Ignasi Barba; Miriam Morente; Rio Aguilar; Esperanza Agulló; Elisatet Miró-Casas; Neus Esquerda; Marisol Ruiz-Meana; David García-Dorado
Journal:  J Physiol       Date:  2010-02-15       Impact factor: 5.182

6.  Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart.

Authors:  Kyriakos N Papanicolaou; Ryosuke Kikuchi; Gladys A Ngoh; Kimberly A Coughlan; Isabel Dominguez; William C Stanley; Kenneth Walsh
Journal:  Circ Res       Date:  2012-08-17       Impact factor: 17.367

Review 7.  Breaking down protein degradation mechanisms in cardiac muscle.

Authors:  Robert C Lyon; Stephan Lange; Farah Sheikh
Journal:  Trends Mol Med       Date:  2013-02-27       Impact factor: 11.951

8.  Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development.

Authors:  Nicola J A Scott; Leigh J Ellmers; John G Lainchbury; Nobuyo Maeda; Oliver Smithies; A Mark Richards; Vicky A Cameron
Journal:  Biochim Biophys Acta       Date:  2009-09-24

9.  The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans.

Authors:  Radoslaw Dobrowolski; Philipp Sasse; Jan W Schrickel; Marcus Watkins; Jung-Sun Kim; Mindaugas Rackauskas; Clemens Troatz; Alexander Ghanem; Klaus Tiemann; Joachim Degen; Feliksas F Bukauskas; Roberto Civitelli; Thorsten Lewalter; Bernd K Fleischmann; Klaus Willecke
Journal:  Hum Mol Genet       Date:  2007-11-13       Impact factor: 6.150

10.  Deletion of the last five C-terminal amino acid residues of connexin43 leads to lethal ventricular arrhythmias in mice without affecting coupling via gap junction channels.

Authors:  Indra Lübkemeier; Robert Pascal Requardt; Xianming Lin; Philipp Sasse; René Andrié; Jan Wilko Schrickel; Halina Chkourko; Feliksas F Bukauskas; Jung-Sun Kim; Marina Frank; Daniela Malan; Jiong Zhang; Angela Wirth; Radoslaw Dobrowolski; Peter J Mohler; Stefan Offermanns; Bernd K Fleischmann; Mario Delmar; Klaus Willecke
Journal:  Basic Res Cardiol       Date:  2013-04-05       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.